The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation.

Pharmaceutics · 2026 · PMC13118698 · PMID 42076140

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Finally, the atorvastatin and liraglutide combination treatment group had the lowest body weight increase (and therefore the greatest reduction in weight gain) from 155 ± 5.1 g to only 224 g, when compared to both the HFD and the HFD/atorvastatin groups; this reduction was highly significant ( p < 0.0001). 3.2.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.